Holen Sie sich die Stockscreener-App
40.63
1.00%
-0.41
Handel nachbörslich:
40.63
Schlusskurs vom Vortag:
$41.04
Offen:
$41.04
24-Stunden-Volumen:
22,638
Relative Volume:
0.37
Marktkapitalisierung:
$229.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.02%
1M Leistung:
+1.15%
6M Leistung:
-6.58%
1J Leistung:
+1.58%
1-Tages-Spanne:
$40.49
$41.15
1-Wochen-Bereich:
$40.26
$41.53
52-Wochen-Spanne:
$35.22
$48.76
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
Firmenname
Spdr Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XPH
Spdr Pharmaceuticals Etf
|
40.63 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
303.31 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
614.91 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
617.46 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
237.37 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
548.09 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf Aktie (XPH) Neueste Nachrichten
Wealthcare Advisory Partners LLC Takes $339,000 Position in SPDR SSgA Ultra Short Term Bond ETF (NYSEARCA:ULST) - Defense World
Short bets on S&P 500 Healthcare sector ease in May; MRNA stays most shorted stock - Seeking Alpha
Kalkine Reports Surge in SPDR S&P 500 Pharma ETF Trading Activity - Kalkine Media
Cetera Investment Advisers Sells 718 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Ameriprise Financial Inc. Decreases Stock Position in SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
2,299 Shares in SPDR S&P Aerospace & Defense ETF (NYSEARCA:XAR) Purchased by D. E. Shaw & Co. Inc. - Defense World
Invesco S&P 500 Pure Growth ETF (NYSEARCA:RPG) Stake Boosted by Ameriprise Financial Inc. - Defense World
D. E. Shaw & Co. Inc. Has $363,000 Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
D. E. Shaw & Co. Inc. Decreases Holdings in SPDR S&P 600 Small Cap Growth ETF (NYSEARCA:SLYG) - Defense World
Bank of America Corp DE Sells 22,425 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Trump Sparks New Chapter In Transatlantic Trade War: What The US Buys From Europe - Benzinga
Captrust Financial Advisors Increases Holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
SPDR S&P International Small Cap ETF (NYSEARCA:GWX) Shares Sold by Focus Partners Wealth - Defense World
1,953 Shares in SPDR S&P Semiconductor ETF (NYSEARCA:XSD) Acquired by Focus Partners Wealth - Defense World
US health authorities to set targets for lowering drug prices - Reuters
Here's How Trump Plans To Tackle Drug Prices, And Why It Might Not Work - inkl
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing DistortionCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Short bets against S&P 500 healthcare stocks climb in April; MRNA retains top shorted ranking - MSN
Stock ETFs Surge on China Tariffs Pact; Bonds, Gold Falter - Yahoo Finance
ETFs on the Move Post U.S.-China Trade Deal - Nasdaq
Pharma ETFs in Focus on Trump's Drug Price Overhaul - Yahoo Finance
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks - Benzinga
A Look at Pharma ETFs After Strong Q1 Earnings - Yahoo Finance
Raymond James Financial Inc. Invests $762,000 in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
SPDR S&P 400 Mid Cap Value ETF (NYSEARCA:MDYV) Shares Bought by Renaissance Technologies LLC - Defense World
Is Healthcare Losing the Status of Safe Haven? ETFs in Focus - TradingView
Best health care ETFs: Top biotech, pharma and medical funds - Bankrate
Russell Investments Group Ltd. Purchases 420 Shares of SPDR MSCI USA Gender Diversity Index ETF (NYSEARCA:SHE) - Defense World
Bank of Montreal Can Reduces Stock Position in SPDR S&P Semiconductor ETF (NYSEARCA:XSD) - Defense World
Bank of Montreal Can Decreases Stock Position in SPDR NYSE Technology ETF (NYSEARCA:XNTK) - Defense World
SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Shares Bought by JPMorgan Chase & Co. - Defense World
Wells Fargo & Company MN Increases Stock Position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Roche (RHHBY): Significant U.S. Investment to Enhance Manufacturing and Innovation - Value The Markets
Healthcare ETFs Tug of War: Insurers Tumble, Pharma Surges - TradingView
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot - Benzinga
UnitedHealth Woes Aren’t Dragging Down the Entire Sector. Here’s Why. - Barron's
6 Best Health Care Funds and ETFs for 2025 | Investing | U.S. News - Money/ US News
ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike - TradingView
Top SA Quant-rated healthcare stocks as Q1 earnings unfold - Seeking Alpha
Tariffs threaten generic drug production and supplyFmr. FDA commissioner (XPH:NYSEARCA) - Seeking Alpha
Trump says pharma tariffs are coming soon (PPH:NASDAQ) - Seeking Alpha
National Bank of Canada FI Has $26,000 Holdings in SPDR Dow Jones International Real Estate ETF (NYSEARCA:RWX) - Defense World
Pharma, MedTech stocks bounce back as Trump pauses tariffs - MSN
Commonwealth Equity Services LLC Has $203,000 Holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies - Benzinga
A $576 Billion Stock-ETF Juggernaut Hit by Extreme Dislocations - Yahoo Finance
Pharma, MedTech stocks bounce back as Trump pauses most tariffs - Seeking Alpha
LPL Financial LLC Increases Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Raymond James Financial Inc. Makes New Investment in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Finanzdaten der Spdr Pharmaceuticals Etf-Aktie (XPH)
Es liegen keine Finanzdaten für Spdr Pharmaceuticals Etf (XPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):